NL-OMON42346尚未招募不适用
Immunogenic Targets for Therapeutic Vaccination for Liver Cancer - ITVALICA
Maag Darm Leverziekten, Clinical Research Bureau0 个研究点目标入组 360 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Adult HCC-patients treated with RFA, TACE, or surgical resection in Erasmus MC, who are planned to be followed up in Erasmus MC for at least 3 months after the intervention.
排除标准
- •Patients who refuse to participate in the study (refusing blood/tissue donation).
- •Patients with a severe immunocompromised medical condition, or patients taking immunosuppressing medication.
研究者
相似试验
招募中
1 期
GcGM3/VSSP in small cell lung cancerCarcinoma, BronchogenicRespiratory Tract NeoplasmsLung NeoplasmsSmall cell lung cancerBronchial NeoplasmsSmall Cell Lung CarcinomaThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesRPCEC00000224Center of Molecular Immunology (CIM)40
招募中
2 期
GcGM3/VSSP in Metastatic melanomaMetastatic melanomaNevi and MelanomasNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms, Nerve TissueMelanomaRPCEC00000223Center of Molecular Immunology (CIM)160
尚未招募
2 期
GcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancerMetastatic hormone-receptor positive and HER2 negative breast cancerBreast NeoplasmsBreast DiseasesRPCEC00000220Center of Molecular Immunology (CIM)286
Unknown
不适用
Feasibility 'innate' allogeneic stem cells transplantioHematological malignancies (hematologische maligniteiten)Allogeneic stem cells transplantation (allogene stamcel transplantatie)Innate immune system (aangeboren immuunsysteem)NL-OMON25484MC UtrechtHeidelberglaan 1003584 CX Utrecht35
招募中
2 期
Therapeutic vaccination: Phase I / II clinical study on patients randomized blinded to the experimental vaccine or placebo regimen. we want to evaluate the safety and the immunogenicity of a vaccine that includes a first administration of the
ChAdOx1.tHIVconsvX product and a second one with MVA.tHIVconsvX in HIV-1 positive adults treated early and able to control the infection for a long time.2024-514581-39-00Ospedale San Raffaele S.r.l., Ospedale San Raffaele S.r.l.33